Cyclic Peptide Therapeutic Agents Discovery: Computational and Artificial Intelligence-Driven Strategies

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Drug Discovery

Background:

• Cyclic peptides are effective modulators of protein-protein interactions, targeting extensive binding interfaces.
• Traditional cyclic peptide development faces resource limitations and challenges in addressing peptide flexibility and complex conformational landscapes.
• Advancements in computational techniques and artificial intelligence (AI) are transforming the drug discovery pipeline.

Purpose of the Study:

• To review state-of-the-art computational and AI-driven strategies for cyclic peptide drug development.
• To examine methods addressing challenges like peptide flexibility, data scarcity, and conformational complexity.
• To discuss the integration of physics-based simulations and deep learning for designing and optimizing cyclic peptide therapeutics.

Main Methods:

• Review of current computational and AI-driven methodologies in cyclic peptide research.
• Analysis of strategies integrating physics-based simulations with deep learning techniques.
• Examination of automated synthesis platforms for experimental validation.

Main Results:

• Computational and AI approaches significantly enhance the cyclic peptide drug discovery pipeline.
• Integration of simulations and deep learning redefines the design and optimization of cyclic peptide therapeutics.
• Automated synthesis accelerates experimental validation, highlighting transformative potential.

Conclusions:

• Computational and AI strategies are crucial for overcoming resource constraints and technical challenges in cyclic peptide development.
• The synergy between advanced computational methods and experimental validation promises to accelerate the delivery of novel cyclic peptide therapeutics.
• Future perspectives focus on enhancing precision and efficiency to address unmet medical needs through innovative cyclic peptide solutions.